A detailed history of M&T Bank Corp transactions in Organon & Co. stock. As of the latest transaction made, M&T Bank Corp holds 98,582 shares of OGN stock, worth $1.98 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
98,582
Previous 96,803 1.84%
Holding current value
$1.98 Million
Previous $1.4 Million 32.83%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$13.78 - $18.8 $24,514 - $33,445
1,779 Added 1.84%
98,582 $1.85 Million
Q4 2023

Feb 06, 2024

SELL
$10.95 - $17.32 $41,719 - $65,989
-3,810 Reduced 3.79%
96,803 $1.4 Million
Q3 2023

Nov 02, 2023

SELL
$16.59 - $23.77 $69,163 - $99,097
-4,169 Reduced 3.98%
100,613 $1.75 Million
Q2 2023

Aug 09, 2023

BUY
$19.27 - $24.63 $92,919 - $118,765
4,822 Added 4.82%
104,782 $2.18 Million
Q1 2023

May 11, 2023

SELL
$21.42 - $32.08 $45,024 - $67,432
-2,102 Reduced 2.06%
99,960 $2.35 Million
Q4 2022

Feb 13, 2023

SELL
$23.31 - $28.61 $1.09 Million - $1.34 Million
-46,961 Reduced 51.1%
44,940 $1.26 Million
Q4 2022

Feb 13, 2023

BUY
$23.31 - $28.61 $1.33 Million - $1.63 Million
57,122 Added 127.11%
102,062 $2.85 Million
Q3 2022

Nov 14, 2022

BUY
$23.4 - $34.25 $169,790 - $248,518
7,256 Added 8.57%
91,901 $2.1 Million
Q2 2022

Aug 05, 2022

BUY
$31.66 - $38.9 $2.65 Million - $3.25 Million
83,553 Added 7651.37%
84,645 $2.79 Million
Q1 2022

May 09, 2022

SELL
$30.45 - $39.36 $2.68 Million - $3.46 Million
-87,967 Reduced 98.77%
1,092 $38,000
Q4 2021

Feb 07, 2022

SELL
$28.67 - $37.13 $285,151 - $369,294
-9,946 Reduced 10.05%
89,059 $2.71 Million
Q3 2021

Oct 28, 2021

SELL
$28.63 - $35.64 $1.49 Million - $1.85 Million
-51,894 Reduced 34.39%
99,005 $3.25 Million
Q2 2021

Aug 13, 2021

BUY
$28.45 - $38.0 $4.29 Million - $5.73 Million
150,899 New
150,899 $4.57 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.12B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.